Previous close | 13.08 |
Open | 13.06 |
Bid | 13.21 x 100 |
Ask | 13.24 x 200 |
Day's range | 13.06 - 13.49 |
52-week range | 9.57 - 21.60 |
Volume | |
Avg. volume | 351,256 |
Market cap | 494.515M |
Beta (5Y monthly) | 1.05 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Orthofix's (OFIX) fourth-quarter earnings and revenues beat their respective consensus estimate. Gross margin expands while the company continues to incur losses at the operating level.
Orthofix Medical Inc (OFIX) released its 8-K filing on March 5, 2024, showcasing a year of substantial growth and operational efficiency
Orthofix Medical Inc. (NASDAQ:OFIX) Q4 2023 Earnings Call Transcript March 5, 2024 Orthofix Medical Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.14. OFIX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome to Orthofix […]